Keppra and Elaprase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Elaprase (idursulfase). Common drug interactions include device related infection among females and infusion related reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Elaprase. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Elaprase?

Elaprase has active ingredients of idursulfase. eHealthMe is studying from 2,235 Elaprase users. Check the latest studies of Elaprase.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

24 people who take Keppra and Elaprase together, and have interactions are studied.

Keppra and Elaprase drug interactions.

What are the common drug interactions of Keppra and Elaprase, by gender? *:

female:

  1. Device related infection
  2. Dyspnoea (difficult or laboured respiration)
  3. Increased upper airway secretion
  4. Moraxella infection (bacterial infection)
  5. Staphylococcal infection (an infection with staphylococcus bacteria)

male:

  1. Infusion related reaction
  2. Death
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Respiratory tract infection
  5. Swelling face
  6. Tachypnoea (a condition of rapid breathing over 20 per minute)
  7. Tremor (trembling or shaking movements in one or more parts of your body)
  8. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  9. Urticaria (rash of round, red welts on the skin that itch intensely)
  10. Wheezing (a high-pitched whistling sound made while you breath)

What are the common drug interactions of Keppra and Elaprase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Renal disorder (kidney disease)
  2. Respiratory distress (difficulty in breathing)
  3. Respiratory failure (inadequate gas exchange by the respiratory system)
  4. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  5. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  6. Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
  7. Deafness bilateral
  8. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  9. Otitis media (inflammation of the middle ear)

10-19:

  1. Infusion related reaction
  2. Dyspnoea (difficult or laboured respiration)
  3. Anaphylactic reaction (serious allergic reaction)
  4. Faecal incontinence (a lack of control over passing stool)
  5. Increased upper airway secretion
  6. Swelling face
  7. Tachypnoea (a condition of rapid breathing over 20 per minute)
  8. Tremor (trembling or shaking movements in one or more parts of your body)
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  10. Wheezing (a high-pitched whistling sound made while you breath)

20-29:

  1. Death
  2. Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
  3. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  4. Pyrexia (fever)
  5. Waist circumference increased

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 16.67%
  2. Pain: 3 people, 12.50%
  3. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 8.33%
  4. Essential Hypertension (primary hypertension): 2 people, 8.33%
  5. Burkholderia Pseudomallei Infection (infection caused by group of bacteria burkholderia pseudomallei): 2 people, 8.33%
  6. Burkholderia Mallei Infection (infection caused by group of bacteria burkholderia mallei): 2 people, 8.33%
  7. Agitation (state of anxiety or nervous excitement): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Elaprase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Keppra and Elaprase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elaprase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elaprase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on levetiracetam and idursulfase (the active ingredients of Keppra and Elaprase, respectively), and Keppra and Elaprase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: